We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-16.97%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.02B
AUM Growth
-$307M
Cap. Flow
-$225M
Cap. Flow %
-2.49%
Top 10 Hldgs %
20.75%
Holding
813
New
30
Increased
168
Reduced
3
Closed
20

Top Buys

Rank Stock Value
1
HLT icon
Hilton Worldwide
HLT
+$11.3M
2
PRNB
Principia Biopharma Inc. Common Stock
PRNB
+$2.97M
3
IVZ icon
Invesco
IVZ
+$1.15M
4
MSFT icon
Microsoft
MSFT
+$13.8K
5
AAPL icon
Apple
AAPL
+$12.4K

Top Sells

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$13.3M
2
WCG
Wellcare Health Plans, Inc.
WCG
+$12.5M
3
INST
Instructure, Inc.
INST
+$9.03M
4
DERM
Dermira, Inc.
DERM
+$8.64M
5
EQH icon
Equitable Holdings
EQH
+$7.36M

Sector Composition

Rank Sector Weight
1 Healthcare 30.92%
2 Technology 19.71%
3 Financials 10.21%
4 Consumer Discretionary 9.38%
5 Communication Services 8.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXAS
201
DELISTED
Exact Sciences
EXAS
$10.5M 0.12%
116,357
+25
+0% +$2.03K
TGTX icon
202
TG Therapeutics
TGTX
$8.19B
$10.4M 0.12%
959,973
+57
+0% +$720
ZGNX
203
DELISTED
Zogenix, Inc.
ZGNX
$10.4M 0.12%
203,700
– –
ZYME icon
204
Zymeworks
ZYME
$1.62B
$10.3M 0.11%
232,269
+14
+0% +$573
AMBA icon
205
Ambarella
AMBA
$3.04B
$10.3M 0.11%
174,323
– –
CLVS
206
DELISTED
Clovis Oncology, Inc.
CLVS
$10.2M 0.11%
999,915
+62
+0% +$497
GPRK icon
207
GeoPark
GPRK
$609M
$10.1M 0.11%
467,000
-1,868
-0.4% -$29.9K
BHVN
208
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$10M 0.11%
188,799
– –
RTX icon
209
RTX Corp
RTX
$290B
$9.93M 0.11%
107,822
– –
OKE icon
210
Oneok
OKE
$56.7B
$9.87M 0.11%
133,393
– –
LNC icon
211
Lincoln National
LNC
$7.92B
$9.81M 0.11%
170,044
– –
KYNB
212
Kyntra Bio
KYNB
$27.4M
$9.7M 0.11%
9,256
– –
TD icon
213
Toronto Dominion Bank
TD
$193B
$9.68M 0.11%
176,351
– –
ANET icon
214
Arista Networks
ANET
$199B
$9.68M 0.11%
778,768
– –
EIDX
215
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$9.64M 0.11%
171,755
– –
ZBH icon
216
Zimmer Biomet
ZBH
$18.8B
$9.49M 0.11%
66,838
– –
RF icon
217
Regions Financial
RF
$26.4B
$9.46M 0.1%
563,711
– –
WMB icon
218
Williams Companies
WMB
$85.8B
$9.37M 0.1%
403,865
– –
GTHX
219
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$9.31M 0.1%
360,409
+22
+0% +$411
TPTX
220
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$9.29M 0.1%
152,640
+12
+0% +$637
GM icon
221
General Motors
GM
$80.9B
$9.19M 0.1%
256,887
– –
HST icon
222
Host Hotels & Resorts
HST
$17.5B
$9.19M 0.1%
506,714
+113
+0% +$1.71K
COR icon
223
Cencora
COR
$62B
$9.17M 0.1%
110,365
+26
+0% +$2.29K
PARA
224
DELISTED
Paramount Global Class B
PARA
$9.1M 0.1%
221,894
– –
EQIX icon
225
Equinix
EQIX
$99.4B
$9.09M 0.1%
15,927
+4
+0% +$2.39K
7 8
9
10 11

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2020 Portfolio in Review

As of Q1 2020, Candriam SCA held 813 positions worth $9.02B, down 3.3% from $9.33B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q1 2020 filing shows 30 new, 168 increased, 3 reduced and 20 closed positions. Its largest new stake was Hilton Worldwide: 116,476 shares worth $21.1M. The largest sale was Medicines Co, an estimated $13.3M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2020 buy was Hilton Worldwide: 116,476 shares worth $21.1M.
  • Candriam SCA added most to Microsoft in Q1 2020, an estimated $13.8K increase.
  • Candriam SCA's biggest Q1 2020 reduction was Telus, cutting an estimated $1.67M.
  • Candriam SCA fully exited Medicines Co in Q1 2020, selling an estimated $13.3M.
  • Candriam SCA's ten largest holdings make up 21% of its $9.02B portfolio in Q1 2020.
  • Candriam SCA opened 30 new positions and closed 20 in Q1 2020.
  • Candriam SCA's portfolio value fell 3.3% quarter-over-quarter to $9.02B.

Based on Candriam SCA's 13F filing for Q1 2020, filed 26 May 2020.